Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Gidal

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The Annals of Pharmacotherapy|February 1, 1995
Perspective on lamotrigineB E Gidal, W R Garnett
Acta Neurologica Scandinavica|May 29, 2012
Vigabatrin-associated retinal damage: potential biochemical mechanismsM K Heim, B E Gidal
Acta Neurologica Scandinavica|May 22, 2015
Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokineticsH A Gefroh-Grimes, B E Gidal
Epilepsy Research|February 11, 2003
Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trialsE Perucca, B E Gidal, Eugène Baltès
Seminars in Pediatric Neurology|October 16, 1999
A 13-year-old with an acute change in mental statusB E Gidal, J N Seltz, P Rutecki
Pharmacotherapy|July 3, 1999
The ketogenic diet. Central Nervous System Practice and Research Network of the American College of Clinical PharmacyJ L Bainbridge, B E Gidal, M Ryan
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|May 25, 2001
Pharmacologic management of epilepsy in the elderlyS V Bourdet, B E Gidal, B K Alldredge
The Annals of Pharmacotherapy|January 1, 1993
Apparent valproic acid neurotoxicity in a hypoalbuminemic patientB E Gidal, D M Collins, B R Beinlich
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 15, 1995
Immunotherapy in multiple sclerosis, Part 1C C Becker, B E Gidal, J O Fleming
The Annals of Pharmacotherapy|October 1, 1993
Potential interaction between carbamazepine and loxapine: case report and retrospective reviewD M Collins, B E Gidal, M E Pitterle
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|February 1, 1995
Perspective on lamotrigineB E Gidal, W R Garnett
Acta Neurologica Scandinavica|May 29, 2012
Vigabatrin-associated retinal damage: potential biochemical mechanismsM K Heim, B E Gidal
Acta Neurologica Scandinavica|May 22, 2015
Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokineticsH A Gefroh-Grimes, B E Gidal
Epilepsy Research|February 11, 2003
Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trialsE Perucca, B E Gidal, Eugène Baltès
Seminars in Pediatric Neurology|October 16, 1999
A 13-year-old with an acute change in mental statusB E Gidal, J N Seltz, P Rutecki
Pharmacotherapy|July 3, 1999
The ketogenic diet. Central Nervous System Practice and Research Network of the American College of Clinical PharmacyJ L Bainbridge, B E Gidal, M Ryan
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|May 25, 2001
Pharmacologic management of epilepsy in the elderlyS V Bourdet, B E Gidal, B K Alldredge
The Annals of Pharmacotherapy|January 1, 1993
Apparent valproic acid neurotoxicity in a hypoalbuminemic patientB E Gidal, D M Collins, B R Beinlich
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 15, 1995
Immunotherapy in multiple sclerosis, Part 1C C Becker, B E Gidal, J O Fleming
The Annals of Pharmacotherapy|October 1, 1993
Potential interaction between carbamazepine and loxapine: case report and retrospective reviewD M Collins, B E Gidal, M E Pitterle
Pageof 6